Related Experiment Video
Updated: Jul 16, 2025

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
Published on: August 16, 2020
A Machine Learning Framework to Improve Rat Clearance Predictions and Inform Physiologically Based Pharmacokinetic
Andrea Andrews-Morger1, Michael Reutlinger1, Neil Parrott1
1Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, 4070 Basel, Switzerland.
Machine learning models accurately predict unbound intrinsic clearance (CLint,u) for physiologically based pharmacokinetic (PBPK) models. This approach improves in vivo clearance predictions compared to traditional methods, reducing the need for extensive in vitro data.
Area of Science:
- Pharmacokinetics and Drug Metabolism
- Computational Chemistry and Molecular Modeling
- Machine Learning in Drug Discovery
Background:
- Physiologically based pharmacokinetic (PBPK) models are crucial for predicting drug efficacy and safety.
- Accurate estimation of unbound intrinsic clearance (CLint,u) is a key challenge in PBPK modeling for drug discovery.
- Current in vitro-to-in vivo extrapolation methods can be complex and require extensive experimental data.
Purpose of the Study:
- To develop and compare machine learning (ML) strategies for predicting rat CLint,u for PBPK applications.
- To evaluate the performance of ML-based predictions against the standard in vitro bottom-up approach.
- To assess the utility of ML models in improving the prediction of in vivo pharmacokinetic parameters.
Main Methods:
- Collected in vivo and in vitro data for 2639 proprietary compounds.
- Developed three ML-based strategies to predict CLint,u, including back-calculation from in vivo data and bias prediction.
- Compared ML approaches with the standard in vitro bottom-up method using temporal cross-validation.
Main Results:
- ML model trained on back-calculated CLint,u achieved an absolute average fold error (AAFE) of 3.1, outperforming the bottom-up approach (AAFE 3.6-16).
- ML model incorporating bias prediction improved AAFE from 16 to 2.9 and log Pearson r^2 from 0.1 to 0.29 compared to bottom-up.
- ML approaches offer advantages such as reduced need for experimental in vitro data and circumvention of certain scaling corrections.
Conclusions:
- Machine learning strategies provide a powerful and accurate alternative for predicting CLint,u in PBPK modeling.
- ML-based prediction of CLint,u can enhance existing drug discovery workflows and improve in vivo pharmacokinetic predictions.
- These computational approaches streamline the drug development process by providing reliable clearance estimates with potentially less experimental burden.
Related Concept Videos
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Clearance Models: Physiological Models
The organ's clearance rate depends on the blood flow to the organ and the extraction ratio (E). The extraction ratio describes the organ's...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Model Approaches for Pharmacokinetic Data: Physiological Models

